| Home | E-Submission | Sitemap | Contact Us |  
top_img
Cancer Research and Treatment > Volume 34(6); 2002 > Article
Cancer Research and Treatment 2002;34(6): 436-438. doi: https://doi.org/10.4143/crt.2002.34.6.436
l-myc Polymorphism in Gastric Cancer, Lung Cancer, and Hepatocellular Carcinoma
Min Su Park, Sae Bin Jung, Yeon Hee Park, Bong Seog Kim, Hyun Ju Park, Hee Jae Lee, Soon Ae Kim, Bong Keun Choe, Joo Ho Chung
1Kohwang Medical Research Institute, College of Medicine,Kyung Hee University, Korea. jhchung@ khu.ac.kr
2Division of Medical Oncology, Korea Cancer Center Hospital,Korea.
3Division of Medical Oncology, Seoul Veterans Hospital,Seoul, Korea.
4Division of Gastroenterology, College of Medicine, HallymUniversity, Pyungchon, Korea.
  Published online: December 31, 2002.
ABSTRACT
PURPOSE:
This study was performed to see if a particular polymorphism in the l-myc, a nuclear oncogene at the 1p32 locus, might be associated with greater risk of gastric cancer, lung cancer and hepatocellular carcinomas (HCC) in Korean patients.
MATERIALS AND METHODS:
Genomic DNA, derived from patients diagnosed with gastric cancer (n=57), lung cancer (n=39), HCC (n=35) and healthy individuals (n= 176), was examined. The l-myc polymorphism under study was visualized by PCR followed by EcoRI digestion.
RESULTS:
There was no significant difference in the distribution of the l-myc polymorphism genotypes and allele frequencies between the cancer patients and the controls.
CONCLUSION:
The l-myc polymorphism does not appear to be indicative of elevated risk of cancers of the stomach, lung and HCC.
Key words: Gastric neoplasm;Lung neoplasm;Hepatocellular carcinoma;l-myc polymorphism
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association.                 Developed in M2PI